Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
about
Glycomic Approaches for the Discovery of Targets in Gastrointestinal CancerHallmarks of glycosylation in cancerElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsHost kinin B1 receptor plays a protective role against melanoma progression.Effects of Glycosylation on the Enzymatic Activity and Mechanisms of ProteasesSimultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic methodSolvent interaction analysis as a proteomic approach to structure-based biomarker discovery and clinical diagnostics.Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometryActivation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis.Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers.The analysis of sialylation, N-glycan branching, and expression of O-glycans in seminal plasma of infertile men.Protein glycosylation in cancer.Carboxybetaine Modified Interface for Electrochemical Glycoprofiling of Antibodies Isolated from Human Serum.Recognition of N-glycoforms in human chorionic gonadotropin by monoclonal antibodies and their interaction motifs.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueA Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.Kallikreins - The melting pot of activity and functionNanoscale controlled architecture for development of ultrasensitive lectin biosensors applicable in glycomics.Glycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods.Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays.Exploring the glycosylation of serum CA125.Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.Predictions for the future of kallikrein-related peptidases in molecular diagnostics.Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations.Relative versus absolute quantitation in disease glycomics.Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylationLabel-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins.Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell ViabilityHigh-throughput analysis of immunoglobulin G glycosylation.The role of glycans in the development and progression of prostate cancer.Can glycoprofiling be helpful in detecting prostate cancer?Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Harnessing Solute Carrier Transporters for Precision Oncology.A universal chemical enrichment method for mapping the yeast N-glycoproteome by mass spectrometry (MS)Specific Identification of Glycoproteins Bearing the Tn Antigen in Human Cells.Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity.Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity.Ultrasensitive impedimetric lectin biosensors with efficient antifouling properties applied in glycoprofiling of human serum samples.Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples.
P2860
Q26750872-74821E52-381D-430E-898B-365008ABBBD1Q26752363-872A6C79-460B-4EA3-B358-CAC418492456Q26822552-6A6F050A-9599-4971-BBC6-15528497A486Q27340170-4600EA4E-2D8F-4DFC-B0FF-0CFABF99E278Q28069869-56414085-6C98-4CC0-B272-0BAB46D2F265Q28468580-78AADC41-E61D-46D4-BDB4-C5F84C337DC3Q30381260-A31A5C8F-0595-4280-89F8-8D1A07A116CFQ30382105-41E6709A-85E0-4034-A5AD-5257920462C2Q33807752-66D033DA-66AA-4B67-8F36-CF4E6473C9BCQ34731651-C9BF4DBB-7186-46B9-B7D1-BC0CDA3C98A8Q34785893-7177FB66-CE18-4211-87A3-E24BB321E262Q35372905-233F1CE6-3305-4652-9F71-F66E69968473Q35413473-0B4EE8AC-D975-41D9-8232-8CDDD10CD5DFQ35654967-6202C2D5-8BC4-4115-8230-83BF9C1AFC0FQ36050006-ABD8097D-9BA4-4F6F-86A9-1F6B1E5455A8Q36278033-6CD8F1A5-A627-4B23-A024-324EBB400FF3Q36442339-E61D4306-77E4-433C-BA36-579DA80B4D6EQ36563056-5FBBCB8B-D7F9-461A-BE65-4E2045D3421AQ36931757-FDAD0705-93C2-4E61-AE92-66A63AFBDBCAQ36943783-4F7D23C4-D2B4-4B25-9439-E5F8BB5C1814Q36945404-8C7A7B65-83D1-4503-990C-E663A4BDA618Q37139074-6D874C73-2164-41F9-A3DC-EB1192313FD7Q38194576-6372C275-ECD6-4B62-AB34-1FE476CBA921Q38220044-FE5177B2-A6FA-478D-9069-E52AE23F4A28Q38258595-C660BDC2-A67F-4FE1-8B5F-B2C8B8FC8614Q38356585-7FD7B4DD-EF78-454B-BE5D-C79612916F26Q38688788-B4819CB1-3BFA-4711-BE7A-E823F571CEDAQ38708626-28F69C31-F54B-4A61-A27B-8016D5F1CBF8Q38757500-1D037AB8-A0DC-45C0-ADC4-2333E80E0887Q38797703-47DFBAEA-BDA2-4FEF-9E41-2C3521817215Q38811520-00FFD076-7C8A-46E8-8F23-AD1B3EFDDB59Q38852467-3E49CFE6-C291-4E12-B3F8-FF056D196F04Q39012279-F5F19333-9BB6-4698-B711-0216F123F231Q39204754-139CB9F0-EF76-4BCA-B80F-FE5EACFDB3D3Q40373402-0B4B4BEA-50B3-40D1-AF60-E69F12AB4014Q41137938-F06B8E45-8EF4-4AA0-91E8-E3A339E676BDQ41817072-9F3BB916-5701-4D80-B091-425D769CA42BQ42370133-5C20F252-A91C-4567-9CF1-28583F9D77B3Q42571075-126EA635-9B17-44C2-B1A6-1601B1C06C2FQ42615371-FE993503-29F5-4F92-9C65-F77F4B92AD1A
P2860
Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
@en
type
label
Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
@en
prefLabel
Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
@en
P2093
P2860
P356
P1476
Aberrant PSA glycosylation--a sweet predictor of prostate cancer
@en
P2093
Pauline M Rudd
Radka Saldova
Richard J O'Kennedy
P2860
P2888
P304
P356
10.1038/NRUROL.2012.258
P407
P577
2013-01-15T00:00:00Z
P5875
P6179
1038144905